Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.890
-0.060 (-1.52%)
Apr 3, 2025, 4:08 PM HKT

Sino Biopharmaceutical Statistics

Total Valuation

HKG:1177 has a market cap or net worth of HKD 69.56 billion. The enterprise value is 75.94 billion.

Market Cap 69.56B
Enterprise Value 75.94B

Important Dates

The last earnings date was Thursday, March 27, 2025.

Earnings Date Mar 27, 2025
Ex-Dividend Date Jun 16, 2025

Share Statistics

HKG:1177 has 17.88 billion shares outstanding. The number of shares has decreased by -1.26% in one year.

Current Share Class n/a
Shares Outstanding 17.88B
Shares Change (YoY) -1.26%
Shares Change (QoQ) -1.25%
Owned by Insiders (%) 50.59%
Owned by Institutions (%) 18.09%
Float 8.83B

Valuation Ratios

The trailing PE ratio is 34.85 and the forward PE ratio is 20.55. HKG:1177's PEG ratio is 1.34.

PE Ratio 34.85
Forward PE 20.55
PS Ratio 2.32
PB Ratio 2.05
P/TBV Ratio 2.26
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio 1.34
Financial Ratio History

Enterprise Valuation

EV / Earnings 20.39
EV / Sales 2.47
EV / EBITDA 11.91
EV / EBIT 14.13
EV / FCF n/a

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.23.

Current Ratio 1.26
Quick Ratio 1.02
Debt / Equity 0.23
Debt / EBITDA 1.60
Debt / FCF n/a
Interest Coverage 17.51

Financial Efficiency

Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 6.25%.

Return on Equity (ROE) 11.82%
Return on Assets (ROA) 5.01%
Return on Invested Capital (ROIC) 6.25%
Return on Capital Employed (ROCE) 11.27%
Revenue Per Employee 1.26M
Profits Per Employee 152,772
Employee Count 24,379
Asset Turnover 0.45
Inventory Turnover 2.44

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +30.64% in the last 52 weeks. The beta is 0.75, so HKG:1177's price volatility has been lower than the market average.

Beta (5Y) 0.75
52-Week Price Change +30.64%
50-Day Moving Average 3.32
200-Day Moving Average 3.22
Relative Strength Index (RSI) 68.77
Average Volume (20 Days) 109,370,322

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:1177 had revenue of HKD 30.72 billion and earned 3.72 billion in profits. Earnings per share was 0.20.

Revenue 30.72B
Gross Profit 25.04B
Operating Income 5.50B
Pretax Income 5.62B
Net Income 3.72B
EBITDA 6.50B
EBIT 5.50B
Earnings Per Share (EPS) 0.20
Full Income Statement

Balance Sheet

The company has 15.53 billion in cash and 10.41 billion in debt, giving a net cash position of 5.12 billion or 0.29 per share.

Cash & Cash Equivalents 15.53B
Total Debt 10.41B
Net Cash 5.12B
Net Cash Per Share 0.29
Equity (Book Value) 45.52B
Book Value Per Share 1.90
Working Capital 5.46B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 81.51%, with operating and profit margins of 17.91% and 12.12%.

Gross Margin 81.51%
Operating Margin 17.91%
Pretax Margin 18.28%
Profit Margin 12.12%
EBITDA Margin 21.16%
EBIT Margin 17.91%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.03%.

Dividend Per Share 0.08
Dividend Yield 2.03%
Dividend Growth (YoY) -25.00%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.26%
Shareholder Yield 3.29%
Earnings Yield 5.35%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.

Last Split Date Jul 20, 2020
Split Type Forward
Split Ratio 1.5

Scores

Altman Z-Score n/a
Piotroski F-Score n/a